{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:17:10Z","timestamp":1769599030888,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NCI, Cairo university","award":["153-17"],"award-info":[{"award-number":["153-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>CD68<\/jats:italic>+ tumor-associated macrophages (TAM) play an important role in the progression of classical Hodgkin lymphoma (cHL). We assessed the role of <jats:italic>CD20<\/jats:italic> and <jats:italic>CD68<\/jats:italic>\u00a0+\u00a0TAM in a cohort of cHL patients from Egypt and correlated the number of <jats:italic>CD68<\/jats:italic>\u00a0+\u00a0cells with patients\u2019 characteristics, response to treatment, overall and progression free survival rates (OS &amp; PFS).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p><jats:italic>CD20<\/jats:italic> expression and <jats:italic>CD68<\/jats:italic>\u2009+\u2009TAM numbers were assessed in representative tumor tissues obtained from 81 cHL patients using flowcytometry (FCM), immunohistochemistry (IHC), and Rt-PCR techniques.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The expression levels of CD68 protein by IHC was high in 27 (33.3%), moderate in 15 (18.5%), low in 15 (18.5%), and negative in 24 (29.6%) patients (<jats:italic>p<\/jats:italic>\u00a0=\u20090.13). CD68-mRNA expression was high in 43\/81(53.1%), and low in 38(46.9%) patients (<jats:italic>p<\/jats:italic>\u00a0=\u20090.6). The number of <jats:italic>CD68<\/jats:italic>\u00a0+\u00a0TAM (by FCM) was low (&lt;\u200920 cells) in 42\/81 (51.9%), and high (\u226520 cells) in 39\/81 (48.1%) patients (<jats:italic>p<\/jats:italic>\u00a0=\u20090.74). <jats:italic>CD68<\/jats:italic> expression (by FCM, IHC&amp; Rt-PCR) associated significantly with poor response to treatment, decreased <jats:italic>CD20<\/jats:italic> expression, reduced OS and PFS rates (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001 for all). CD68 expression (by Rt-PCR only) associated significantly with advanced disease stage (<jats:italic>p<\/jats:italic>\u00a0=\u20090.04). The age of the patients, high <jats:italic>CD20<\/jats:italic> expression &amp; high <jats:italic>CD68+<\/jats:italic> macrophage number were independent prognostic factors for OS (<jats:italic>p<\/jats:italic>=\u20090.02, <jats:italic>p<\/jats:italic>\u00a0=\u20090.008 &amp; <jats:italic>p<\/jats:italic>\u00a0=\u20090.009; respectively). However, the age of the patient, high CD20, and high CD68+ macrophage expression (by FCM&amp;IHC) were independent prognostic factors for DFS (<jats:italic>p<\/jats:italic>.\u2009=\u20090.004, <jats:italic>p<\/jats:italic>.\u2009=\u20090.01, <jats:italic>p<\/jats:italic>.\u2009=\u20090.007 and <jats:italic>p<\/jats:italic>.\u2009=\u20090.01; respectively).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p><jats:italic>CD68<\/jats:italic>\u00a0+\u00a0TAM expression (by Rt-PCR, FCM and\/or IHC) can identify patients with poor response to treatment and reduced survival rates (OS&amp; PFS). Assessment of <jats:italic>CD68<\/jats:italic>\u00a0+\u00a0positive macrophages by FCM is superior to other methods (Rt-PCR and IHC) as a prognostic factor for DFS and OS rates.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13000-019-0912-3","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T18:02:54Z","timestamp":1580839374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt"],"prefix":"10.1186","volume":"15","author":[{"given":"Osama","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El Bastawisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasr","family":"Allahlobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona S.","family":"Abdellateif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Rahman N.","family":"Zekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabry","family":"Shaarawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Korany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Mohanad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer A.","family":"Bahnassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"issue":"4","key":"912_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/cancers10040091","volume":"10","author":"C Cuceu","year":"2018","unstructured":"Cuceu C, Hempel W, Sabatier L, Bosq J, Carde P, M\u2019kacher R. Chromosomal instability in hodgkin lymphoma: an in-depth review and perspectives. Cancers. 2018;10(4):91.","journal-title":"Cancers."},{"issue":"31\u201332","key":"912_CR2","first-page":"535","volume":"115","author":"PJ Br\u00f6ckelmann","year":"2018","unstructured":"Br\u00f6ckelmann PJ, Eichenauer DA, Jakob T, Follmann M, Engert A, Skoetz N. Hodgkin lymphoma in adults: diagnosis, treatment, and follow-up. Dtsch Arztebl Int. 2018;115(31\u201332):535.","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"912_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ncponc1186","volume":"5","author":"AM Evens","year":"2008","unstructured":"Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol. 2008;5(9):543\u201356.","journal-title":"Nat Clin Pract Oncol"},{"issue":"4","key":"912_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbmt.2011.08.012","volume":"18","author":"SF Keller","year":"2012","unstructured":"Keller SF, Kelly JL, Sensenig E, et al. Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin\u2019s lymphoma (HL) in the ABVD therapeutic era. Biol Blood Marrow Transplant. 2012;18(4):640\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"912_CR5","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood."},{"issue":"3","key":"912_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.biocel.2003.10.025","volume":"37","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers R, Hansmann ML. The Hodgkin and reed\/Sternberg cell. Int J Biochem Cell Biol. 2005 Mar 1;37(3):511\u20137.","journal-title":"Int J Biochem Cell Biol"},{"issue":"14","key":"912_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","volume":"29","author":"C Steidl","year":"2011","unstructured":"Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol. 2011;29(14):1812\u201326.","journal-title":"J Clin Oncol"},{"key":"912_CR8","unstructured":"Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. Int Agency Res Cancer. 2017;2:439. ISBN: 9789283224310."},{"issue":"26","key":"912_CR9","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1200\/JCO.2005.55.013","volume":"23","author":"D Re","year":"2005","unstructured":"Re D, Kuppers R, Diehl V. Molecular pathogenesis of Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23(26):6379\u201386.","journal-title":"J Clin Oncol"},{"issue":"1","key":"912_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R Kuppers","year":"2009","unstructured":"Kuppers R. The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer. 2009;9(1):15\u201327.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"912_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1080\/10428190410001683633","volume":"45","author":"D Aldinucci","year":"2004","unstructured":"Aldinucci D, Lorenzon D, Olivo K, Rapana B, Gattei V. Interactions between tissue fibroblasts in lymph nodes and Hodgkin\/reed-stern-berg cells. Leuk Lymphoma. 2004;45(9):1731\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"912_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.matbio.2010.10.004","volume":"30","author":"H Xu","year":"2011","unstructured":"Xu H, Raynal N, Stathopoulos S, Myllyharju J, Farndale RW, Leitinger B. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biol. 2011;30(1):16\u201326.","journal-title":"Matrix Biol"},{"issue":"26","key":"912_CR13","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1182\/blood-2013-11-534123","volume":"122","author":"A Carbone","year":"2013","unstructured":"Carbone A, Gloghini A. Activated DDR1 increases RS cell survival. Blood. 2013;122(26):4152\u20134.","journal-title":"Blood."},{"issue":"21","key":"912_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351(21):2159\u201369.","journal-title":"N Engl J Med"},{"issue":"4","key":"912_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","volume":"11","author":"T \u00c1lvaro","year":"2005","unstructured":"\u00c1lvaro T, Lejeune M, Salvad\u00f3 MT, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res. 2005;11(4):1467\u201373.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"912_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel J, Chadburn A, Rubinstein PG, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and reed-Sternberg cells. Blood. 2015;125(7):1061\u201372.","journal-title":"Blood."},{"issue":"3","key":"912_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hon.2295","volume":"35","author":"M Gotti","year":"2017","unstructured":"Gotti M, Nicola M, Lucioni M, Fiaccadori V, Ferretti V, Sciarra R, Costanza M, Bono E, Molo S, Maffi A, Croci GA. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma. Hematol Oncol. 2017 Sep;35(3):296\u2013302.","journal-title":"Hematol Oncol"},{"issue":"1","key":"912_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/hon.2249","volume":"35","author":"E Cencini","year":"2017","unstructured":"Cencini E, Fabbri A, Rigacci L, Lazzi S, Gini G, Cox MC, Mancuso S, Abruzzese E, Kovalchuk S, Goteri G, Di Napoli A. Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. Hematol Oncol. 2017 Mar;35(1):69\u201378.","journal-title":"Hematol Oncol"},{"key":"912_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"912_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"5","key":"912_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/jcp.55.5.359","volume":"55","author":"MP Leers","year":"2002","unstructured":"Leers MP, Schoffelen RH, Hoop JG, et al. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol. 2002;55(5):359\u201366.","journal-title":"J Clin Pathol"},{"issue":"10","key":"912_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, et al. Tumor associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med. 2010;362(10):875\u201385.","journal-title":"N Engl J Med"},{"issue":"1","key":"912_CR23","doi-asserted-by":"publisher","first-page":"e87066","DOI":"10.1371\/journal.pone.0087066","volume":"9","author":"YW Koh","year":"2014","unstructured":"Koh YW, Park CS, Yoon DH, Suh C, Huh J. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma. PLoS One. 2014;9(1):e87066.","journal-title":"PLoS One"},{"issue":"2","key":"912_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2011.39.9881","volume":"31","author":"P Greaves","year":"2013","unstructured":"Greaves P, Clear A, Coutinho R, et al. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol. 2013;31(2):256.","journal-title":"J Clin Oncol"},{"issue":"2","key":"912_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2010.031542","volume":"96","author":"P Kamper","year":"2011","unstructured":"Kamper P, Bendix K, Hamilton-Dutoit S, Honore B, Nyengaard JR, d\u2019Amore F. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin\u2019s lymphoma. Haematologica. 2011;96(2):269\u201376 [PubMed: 21071500].","journal-title":"Haematologica."},{"issue":"2","key":"912_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2141.2002.03815.x","volume":"119","author":"GL Stark","year":"2002","unstructured":"Stark GL, Wood KM, Jack F, et al. Northern region lymphoma group. Hodgkin\u2019s disease in the elderly: a population-based study. Br J Haematol. 2002;119(2):432\u201340 [PubMed: 12406082].","journal-title":"Br J Haematol"},{"issue":"3","key":"912_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/annonc\/mdr157","volume":"23","author":"D Azambuja","year":"2011","unstructured":"Azambuja D, Natkunam Y, Biasoli I, et al. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Ann Oncol. 2011;23(3):736\u201342.","journal-title":"Ann Oncol"},{"issue":"5","key":"912_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3109\/10428194.2014.963081","volume":"56","author":"A Agur","year":"2015","unstructured":"Agur A, Amir G, Paltiel O, et al. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma. Leuk Lymphoma. 2015;56(5):1315\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"912_CR29","first-page":"1031","volume":"55","author":"S Kayal","year":"2014","unstructured":"Kayal S, Mathur S, Karak AK, et al. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma. Leuklymphoma. 2014;55(5):1031\u20137.","journal-title":"Leuklymphoma."},{"issue":"3","key":"912_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/cam4.585","volume":"5","author":"A Cuccaro","year":"2016","unstructured":"Cuccaro A, Annunziata S, Cupelli E, et al. CD 68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma. Cancer medicine. 2016;5(3):398\u2013406.","journal-title":"Cancer medicine"},{"issue":"1","key":"912_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12916-016-0711-6","volume":"14","author":"B Guo","year":"2016","unstructured":"Guo B, Cen H, Tan X, Ke Q. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma. BMC Med. 2016;14(1):159.","journal-title":"BMC Med"},{"issue":"6","key":"912_CR32","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3109\/10428194.2014.951849","volume":"56","author":"L Panico","year":"2015","unstructured":"Panico L, Tenneriello V, Ronconi F, et al. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages. Leuk Lymphoma. 2015;56(6):1636\u201342.","journal-title":"Leuk Lymphoma"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0912-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0912-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0912-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:30:17Z","timestamp":1612312217000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0912-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0912-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed according to the guidelines of 2011 declaration of Helsinki as well as with the guidelines of a good clinical practice. The Ethical Committee of the NCI, Cairo University approved the study protocol and a written informed consent was obtained from each patient or control subject prior to enrolment in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}